Mortality  ||| S:0 E:10 ||| NN
in  ||| S:10 E:13 ||| IN
the  ||| S:13 E:17 ||| DT
Veneto  ||| S:17 E:24 ||| JJ
population  ||| S:24 E:35 ||| NN
on  ||| S:35 E:38 ||| IN
renal  ||| S:38 E:44 ||| JJ
replacement  ||| S:44 E:56 ||| NN
therapy  ||| S:56 E:64 ||| NN
This  ||| S:64 E:69 ||| DT
section  ||| S:69 E:77 ||| NN
reports  ||| S:77 E:85 ||| NNS
survival  ||| S:85 E:94 ||| NN
rates  ||| S:94 E:100 ||| NNS
for  ||| S:100 E:104 ||| IN
patients  ||| S:104 E:113 ||| NNS
on  ||| S:113 E:116 ||| IN
renal  ||| S:116 E:122 ||| JJ
replacement  ||| S:122 E:134 ||| NN
therapy  ||| S:134 E:142 ||| NN
( ||| S:142 E:143 ||| -LRB-
RRT ||| S:143 E:146 ||| NNP
) ||| S:146 E:147 ||| -RRB-
.  ||| S:147 E:149 ||| .
The  ||| S:149 E:153 ||| DT
data  ||| S:153 E:158 ||| NNS
obtained  ||| S:158 E:167 ||| VBN
from  ||| S:167 E:172 ||| IN
the  ||| S:172 E:176 ||| DT
Veneto  ||| S:176 E:183 ||| NNP
Dialysis  ||| S:183 E:192 ||| NNP
and  ||| S:192 E:196 ||| CC
Transplantation  ||| S:196 E:212 ||| NNP
Registry  ||| S:212 E:221 ||| NNP
( ||| S:221 E:222 ||| -LRB-
VDTR ||| S:222 E:226 ||| NNP
)  ||| S:226 E:228 ||| -RRB-
cover  ||| S:228 E:234 ||| VB
the  ||| S:234 E:238 ||| DT
whole  ||| S:238 E:244 ||| JJ
population  ||| S:244 E:255 ||| NN
in  ||| S:255 E:258 ||| IN
the  ||| S:258 E:262 ||| DT
region ||| S:262 E:268 ||| NN
.  ||| S:268 E:270 ||| .
Patients  ||| S:270 E:279 ||| NNS
on  ||| S:279 E:282 ||| IN
RRT  ||| S:282 E:286 ||| NNP
alive  ||| S:286 E:292 ||| JJ
on  ||| S:292 E:295 ||| IN
31  ||| S:295 E:298 ||| CD
December  ||| S:298 E:307 ||| NNP
of  ||| S:307 E:310 ||| IN
each  ||| S:310 E:315 ||| DT
year  ||| S:315 E:320 ||| NN
were  ||| S:320 E:325 ||| VBD
assumed  ||| S:325 E:333 ||| VBN
to  ||| S:333 E:336 ||| TO
be  ||| S:336 E:339 ||| VB
at  ||| S:339 E:342 ||| IN
risk  ||| S:342 E:347 ||| NN
of  ||| S:347 E:350 ||| IN
dying  ||| S:350 E:356 ||| VBG
in  ||| S:356 E:359 ||| IN
the  ||| S:359 E:363 ||| DT
following  ||| S:363 E:373 ||| JJ
year ||| S:373 E:377 ||| NN
.  ||| S:377 E:379 ||| .
Furthermore ||| S:379 E:390 ||| RB
,  ||| S:390 E:392 ||| ,
time-to-event  ||| S:392 E:406 ||| JJ
analysis  ||| S:406 E:415 ||| NN
was  ||| S:415 E:419 ||| VBD
used  ||| S:419 E:424 ||| VBN
to  ||| S:424 E:427 ||| TO
describe  ||| S:427 E:436 ||| VB
the  ||| S:436 E:440 ||| DT
complete  ||| S:440 E:449 ||| JJ
history  ||| S:449 E:457 ||| NN
of  ||| S:457 E:460 ||| IN
patients  ||| S:460 E:469 ||| NNS
from  ||| S:469 E:474 ||| IN
when  ||| S:474 E:479 ||| WRB
they  ||| S:479 E:484 ||| PRP
started  ||| S:484 E:492 ||| VBD
RRT  ||| S:492 E:496 ||| NNP
until  ||| S:496 E:502 ||| IN
they  ||| S:502 E:507 ||| PRP
died ||| S:507 E:511 ||| VBD
,  ||| S:511 E:513 ||| ,
including  ||| S:513 E:523 ||| VBG
transitions  ||| S:523 E:535 ||| NN
between  ||| S:535 E:543 ||| IN
the  ||| S:543 E:547 ||| DT
3  ||| S:547 E:549 ||| CD
main  ||| S:549 E:554 ||| JJ
treatment  ||| S:554 E:564 ||| NN
modalities  ||| S:564 E:575 ||| NNS
-  ||| S:575 E:577 ||| :
hemodialysis  ||| S:577 E:590 ||| CD
( ||| S:590 E:591 ||| -LRB-
HD ||| S:591 E:593 ||| NNP
) ||| S:593 E:594 ||| -RRB-
,  ||| S:594 E:596 ||| ,
peritoneal  ||| S:596 E:607 ||| JJ
dialysis  ||| S:607 E:616 ||| NN
( ||| S:616 E:617 ||| -LRB-
PD ||| S:617 E:619 ||| NNP
)  ||| S:619 E:621 ||| -RRB-
and  ||| S:621 E:625 ||| CC
renal  ||| S:625 E:631 ||| JJ
transplantation ||| S:631 E:646 ||| NN
.  ||| S:646 E:648 ||| .
The  ||| S:648 E:652 ||| DT
cohort  ||| S:652 E:659 ||| NN
of  ||| S:659 E:662 ||| IN
patients  ||| S:662 E:671 ||| NNS
starting  ||| S:671 E:680 ||| VBG
RRT  ||| S:680 E:684 ||| NNP
from  ||| S:684 E:689 ||| IN
1998  ||| S:689 E:694 ||| CD
to  ||| S:694 E:697 ||| TO
2010  ||| S:697 E:702 ||| CD
was  ||| S:702 E:706 ||| VBD
followed  ||| S:706 E:715 ||| VBN
up  ||| S:715 E:718 ||| RP
until  ||| S:718 E:724 ||| IN
31  ||| S:724 E:727 ||| CD
December  ||| S:727 E:736 ||| NNP
2010 ||| S:736 E:740 ||| CD
.  ||| S:740 E:742 ||| .
Survival  ||| S:742 E:751 ||| NN
rates  ||| S:751 E:757 ||| NNS
from  ||| S:757 E:762 ||| IN
the  ||| S:762 E:766 ||| DT
first  ||| S:766 E:772 ||| JJ
treatment  ||| S:772 E:782 ||| NN
to  ||| S:782 E:785 ||| TO
death  ||| S:785 E:791 ||| NN
were  ||| S:791 E:796 ||| VBD
calculated  ||| S:796 E:807 ||| VBN
according  ||| S:807 E:817 ||| VBG
to  ||| S:817 E:820 ||| TO
the  ||| S:820 E:824 ||| DT
life  ||| S:824 E:829 ||| NN
table  ||| S:829 E:835 ||| NN
method ||| S:835 E:841 ||| NN
.  ||| S:841 E:843 ||| .
Relative  ||| S:843 E:852 ||| JJ
survival  ||| S:852 E:861 ||| NN
and  ||| S:861 E:865 ||| CC
excess  ||| S:865 E:872 ||| JJ
mortality  ||| S:872 E:882 ||| NN
rates  ||| S:882 E:888 ||| NNS
were  ||| S:888 E:893 ||| VBD
estimated  ||| S:893 E:903 ||| VBN
according  ||| S:903 E:913 ||| VBG
to  ||| S:913 E:916 ||| TO
the  ||| S:916 E:920 ||| DT
Ederer  ||| S:920 E:927 ||| NNP
II  ||| S:927 E:930 ||| NNP
method ||| S:930 E:936 ||| NN
.  ||| S:936 E:938 ||| .
A  ||| S:938 E:940 ||| DT
multistate  ||| S:940 E:951 ||| JJ
model  ||| S:951 E:957 ||| NN
was  ||| S:957 E:961 ||| VBD
used  ||| S:961 E:966 ||| VBN
to  ||| S:966 E:969 ||| TO
describe  ||| S:969 E:978 ||| VB
changes  ||| S:978 E:986 ||| NNS
in  ||| S:986 E:989 ||| IN
a  ||| S:989 E:991 ||| DT
patient ||| S:991 E:998 ||| NN
's  ||| S:998 E:1001 ||| POS
condition  ||| S:1001 E:1011 ||| NN
( ||| S:1011 E:1012 ||| -LRB-
changes  ||| S:1012 E:1020 ||| NNS
of  ||| S:1020 E:1023 ||| IN
treatment ||| S:1023 E:1032 ||| NN
,  ||| S:1032 E:1034 ||| ,
or  ||| S:1034 E:1037 ||| CC
death ||| S:1037 E:1042 ||| NN
)  ||| S:1042 E:1044 ||| -RRB-
over  ||| S:1044 E:1049 ||| IN
time ||| S:1049 E:1053 ||| NN
.  ||| S:1053 E:1055 ||| .
Among  ||| S:1055 E:1061 ||| IN
prevalent  ||| S:1061 E:1071 ||| JJ
patients  ||| S:1071 E:1080 ||| NNS
on  ||| S:1080 E:1083 ||| IN
RRT ||| S:1083 E:1086 ||| NNP
,  ||| S:1086 E:1088 ||| ,
the  ||| S:1088 E:1092 ||| DT
annual  ||| S:1092 E:1099 ||| JJ
risk  ||| S:1099 E:1104 ||| NN
of  ||| S:1104 E:1107 ||| IN
death  ||| S:1107 E:1113 ||| NN
was  ||| S:1113 E:1117 ||| VBD
10.65 ||| S:1117 E:1122 ||| CD
%  ||| S:1122 E:1124 ||| NN
in  ||| S:1124 E:1127 ||| IN
2008 ||| S:1127 E:1131 ||| CD
,  ||| S:1131 E:1133 ||| ,
9.35 ||| S:1133 E:1137 ||| CD
%  ||| S:1137 E:1139 ||| NN
in  ||| S:1139 E:1142 ||| IN
2009  ||| S:1142 E:1147 ||| CD
and  ||| S:1147 E:1151 ||| CC
8.86 ||| S:1151 E:1155 ||| CD
%  ||| S:1155 E:1157 ||| NN
in  ||| S:1157 E:1160 ||| IN
2010 ||| S:1160 E:1164 ||| CD
.  ||| S:1164 E:1166 ||| .
The  ||| S:1166 E:1170 ||| DT
overall  ||| S:1170 E:1178 ||| JJ
mortality  ||| S:1178 E:1188 ||| NN
rate  ||| S:1188 E:1193 ||| NN
was  ||| S:1193 E:1197 ||| VBD
12.5  ||| S:1197 E:1202 ||| CD
per  ||| S:1202 E:1206 ||| IN
100  ||| S:1206 E:1210 ||| CD
patient-years  ||| S:1210 E:1224 ||| NNS
( ||| S:1224 E:1225 ||| -LRB-
95 ||| S:1225 E:1227 ||| CD
%  ||| S:1227 E:1229 ||| NN
confidence  ||| S:1229 E:1240 ||| NN
interval  ||| S:1240 E:1249 ||| NNS
[ ||| S:1249 E:1250 ||| -LRB-
95 ||| S:1250 E:1252 ||| CD
%  ||| S:1252 E:1254 ||| NN
CI ||| S:1254 E:1256 ||| NNP
] ||| S:1256 E:1257 ||| -RRB-
,  ||| S:1257 E:1259 ||| ,
12.1-13.0 ||| S:1259 E:1268 ||| CD
) ||| S:1268 E:1269 ||| -RRB-
.  ||| S:1269 E:1271 ||| .
The  ||| S:1271 E:1275 ||| DT
5-year  ||| S:1275 E:1282 ||| JJ
relative  ||| S:1282 E:1291 ||| JJ
survival  ||| S:1291 E:1300 ||| NN
was  ||| S:1300 E:1304 ||| VBD
59 ||| S:1304 E:1306 ||| CD
%  ||| S:1306 E:1308 ||| NN
( ||| S:1308 E:1309 ||| -LRB-
95 ||| S:1309 E:1311 ||| CD
%  ||| S:1311 E:1313 ||| NN
CI ||| S:1313 E:1315 ||| NNP
,  ||| S:1315 E:1317 ||| ,
57 ||| S:1317 E:1319 ||| CD
% ||| S:1319 E:1320 ||| NN
-60 ||| S:1320 E:1323 ||| CD
% ||| S:1323 E:1324 ||| NN
) ||| S:1324 E:1325 ||| -RRB-
,  ||| S:1325 E:1327 ||| ,
and  ||| S:1327 E:1331 ||| CC
at  ||| S:1331 E:1334 ||| IN
10  ||| S:1334 E:1337 ||| CD
years  ||| S:1337 E:1343 ||| NNS
relative  ||| S:1343 E:1352 ||| JJ
survival  ||| S:1352 E:1361 ||| NN
was  ||| S:1361 E:1365 ||| VBD
41 ||| S:1365 E:1367 ||| CD
%  ||| S:1367 E:1369 ||| NN
( ||| S:1369 E:1370 ||| -LRB-
95 ||| S:1370 E:1372 ||| CD
%  ||| S:1372 E:1374 ||| NN
CI ||| S:1374 E:1376 ||| NNP
,  ||| S:1376 E:1378 ||| ,
39 ||| S:1378 E:1380 ||| CD
% ||| S:1380 E:1381 ||| NN
-43 ||| S:1381 E:1384 ||| CD
% ||| S:1384 E:1385 ||| NN
) ||| S:1385 E:1386 ||| -RRB-
;  ||| S:1386 E:1388 ||| :
the  ||| S:1388 E:1392 ||| DT
estimated  ||| S:1392 E:1402 ||| JJ
excess  ||| S:1402 E:1409 ||| JJ
mortality  ||| S:1409 E:1419 ||| NN
rate  ||| S:1419 E:1424 ||| NN
was  ||| S:1424 E:1428 ||| VBD
very  ||| S:1428 E:1433 ||| RB
high  ||| S:1433 E:1438 ||| JJ
at  ||| S:1438 E:1441 ||| IN
the  ||| S:1441 E:1445 ||| DT
start  ||| S:1445 E:1451 ||| NN
of  ||| S:1451 E:1454 ||| IN
RRT  ||| S:1454 E:1458 ||| NNP
( ||| S:1458 E:1459 ||| -LRB-
18  ||| S:1459 E:1462 ||| CD
per  ||| S:1462 E:1466 ||| IN
100  ||| S:1466 E:1470 ||| CD
patient-years ||| S:1470 E:1483 ||| NN
)  ||| S:1483 E:1485 ||| -RRB-
but  ||| S:1485 E:1489 ||| CC
gradually  ||| S:1489 E:1499 ||| RB
decreased  ||| S:1499 E:1509 ||| VBN
after  ||| S:1509 E:1515 ||| IN
the  ||| S:1515 E:1519 ||| DT
second  ||| S:1519 E:1526 ||| JJ
year ||| S:1526 E:1530 ||| NN
.  ||| S:1530 E:1532 ||| .
On  ||| S:1532 E:1535 ||| IN
multivariate  ||| S:1535 E:1548 ||| JJ
analysis ||| S:1548 E:1556 ||| NN
,  ||| S:1556 E:1558 ||| ,
excess  ||| S:1558 E:1565 ||| JJ
mortality  ||| S:1565 E:1575 ||| NN
was  ||| S:1575 E:1579 ||| VBD
associated  ||| S:1579 E:1590 ||| VBN
with  ||| S:1590 E:1595 ||| IN
age  ||| S:1595 E:1599 ||| NN
and  ||| S:1599 E:1603 ||| CC
primary  ||| S:1603 E:1611 ||| JJ
renal  ||| S:1611 E:1617 ||| JJ
diseases ||| S:1617 E:1625 ||| NNS
.  ||| S:1625 E:1627 ||| .
Less  ||| S:1627 E:1632 ||| RBR
than  ||| S:1632 E:1637 ||| IN
10 ||| S:1637 E:1639 ||| CD
%  ||| S:1639 E:1641 ||| NN
of  ||| S:1641 E:1644 ||| IN
patients  ||| S:1644 E:1653 ||| NNS
starting  ||| S:1653 E:1662 ||| VBG
on  ||| S:1662 E:1665 ||| IN
PD  ||| S:1665 E:1668 ||| NNP
shifted  ||| S:1668 E:1676 ||| VBD
to  ||| S:1676 E:1679 ||| TO
HD  ||| S:1679 E:1682 ||| NNP
in  ||| S:1682 E:1685 ||| IN
the  ||| S:1685 E:1689 ||| DT
first  ||| S:1689 E:1695 ||| JJ
year  ||| S:1695 E:1700 ||| NN
of  ||| S:1700 E:1703 ||| IN
RRT ||| S:1703 E:1706 ||| NNP
,  ||| S:1706 E:1708 ||| ,
and  ||| S:1708 E:1712 ||| CC
a  ||| S:1712 E:1714 ||| DT
considerable  ||| S:1714 E:1727 ||| JJ
proportion  ||| S:1727 E:1738 ||| NN
received  ||| S:1738 E:1747 ||| VBD
a  ||| S:1747 E:1749 ||| DT
transplant ||| S:1749 E:1759 ||| NN
,  ||| S:1759 E:1761 ||| ,
amounting  ||| S:1761 E:1771 ||| VBG
to  ||| S:1771 E:1774 ||| TO
6 ||| S:1774 E:1775 ||| CD
%  ||| S:1775 E:1777 ||| NN
in  ||| S:1777 E:1780 ||| IN
the  ||| S:1780 E:1784 ||| DT
first  ||| S:1784 E:1790 ||| JJ
year ||| S:1790 E:1794 ||| NN
,  ||| S:1794 E:1796 ||| ,
and  ||| S:1796 E:1800 ||| CC
thereafter  ||| S:1800 E:1811 ||| RB
increasing  ||| S:1811 E:1822 ||| VBG
steadily ||| S:1822 E:1830 ||| RB
:  ||| S:1830 E:1832 ||| :
at  ||| S:1832 E:1835 ||| IN
the  ||| S:1835 E:1839 ||| DT
end  ||| S:1839 E:1843 ||| NN
of  ||| S:1843 E:1846 ||| IN
the  ||| S:1846 E:1850 ||| DT
fifth  ||| S:1850 E:1856 ||| JJ
year ||| S:1856 E:1860 ||| NN
,  ||| S:1860 E:1862 ||| ,
34 ||| S:1862 E:1864 ||| CD
%  ||| S:1864 E:1866 ||| NN
of  ||| S:1866 E:1869 ||| IN
patients  ||| S:1869 E:1878 ||| NNS
starting  ||| S:1878 E:1887 ||| VBG
RRT  ||| S:1887 E:1891 ||| NNP
on  ||| S:1891 E:1894 ||| IN
PD  ||| S:1894 E:1897 ||| NNP
had  ||| S:1897 E:1901 ||| VBD
received  ||| S:1901 E:1910 ||| VBN
a  ||| S:1910 E:1912 ||| DT
transplant ||| S:1912 E:1922 ||| NN
.  ||| S:1922 E:1924 ||| .
HD  ||| S:1924 E:1927 ||| NNP
patients  ||| S:1927 E:1936 ||| NNS
behaved  ||| S:1936 E:1944 ||| VBD
differently ||| S:1944 E:1955 ||| RB
:  ||| S:1955 E:1957 ||| :
any  ||| S:1957 E:1961 ||| DT
shift  ||| S:1961 E:1967 ||| NN
to  ||| S:1967 E:1970 ||| TO
PD  ||| S:1970 E:1973 ||| NNP
was  ||| S:1973 E:1977 ||| VBD
negligible ||| S:1977 E:1987 ||| JJ
,  ||| S:1987 E:1989 ||| ,
and  ||| S:1989 E:1993 ||| CC
the  ||| S:1993 E:1997 ||| DT
patients  ||| S:1997 E:2006 ||| NNS
receiving  ||| S:2006 E:2016 ||| VBG
a  ||| S:2016 E:2018 ||| DT
transplant  ||| S:2018 E:2029 ||| NN
amounted  ||| S:2029 E:2038 ||| VBD
to  ||| S:2038 E:2041 ||| TO
only  ||| S:2041 E:2046 ||| RB
2 ||| S:2046 E:2047 ||| CD
%  ||| S:2047 E:2049 ||| NN
in  ||| S:2049 E:2052 ||| IN
the  ||| S:2052 E:2056 ||| DT
first  ||| S:2056 E:2062 ||| JJ
year  ||| S:2062 E:2067 ||| NN
and  ||| S:2067 E:2071 ||| CC
about  ||| S:2071 E:2077 ||| IN
16 ||| S:2077 E:2079 ||| CD
%  ||| S:2079 E:2081 ||| NN
by  ||| S:2081 E:2084 ||| IN
the  ||| S:2084 E:2088 ||| DT
end  ||| S:2088 E:2092 ||| NN
of  ||| S:2092 E:2095 ||| IN
the  ||| S:2095 E:2099 ||| DT
fifth  ||| S:2099 E:2105 ||| JJ
year ||| S:2105 E:2109 ||| NN
.  ||| S:2109 E:2111 ||| .
Cumulative  ||| S:2111 E:2122 ||| JJ
mortality  ||| S:2122 E:2132 ||| NN
among  ||| S:2132 E:2138 ||| IN
HD  ||| S:2138 E:2141 ||| NNP
patients  ||| S:2141 E:2150 ||| NNS
was  ||| S:2150 E:2154 ||| VBD
particularly  ||| S:2154 E:2167 ||| RB
high  ||| S:2167 E:2172 ||| JJ
( ||| S:2172 E:2173 ||| -LRB-
already  ||| S:2173 E:2181 ||| RB
18 ||| S:2181 E:2183 ||| CD
%  ||| S:2183 E:2185 ||| NN
at  ||| S:2185 E:2188 ||| IN
1  ||| S:2188 E:2190 ||| CD
year ||| S:2190 E:2194 ||| NN
,  ||| S:2194 E:2196 ||| ,
and  ||| S:2196 E:2200 ||| CC
70 ||| S:2200 E:2202 ||| CD
%  ||| S:2202 E:2204 ||| NN
at  ||| S:2204 E:2207 ||| IN
10  ||| S:2207 E:2210 ||| CD
years ||| S:2210 E:2215 ||| NNS
)  ||| S:2215 E:2217 ||| -RRB-
by  ||| S:2217 E:2220 ||| IN
comparison  ||| S:2220 E:2231 ||| NN
with  ||| S:2231 E:2236 ||| IN
those  ||| S:2236 E:2242 ||| DT
on  ||| S:2242 E:2245 ||| IN
PD  ||| S:2245 E:2248 ||| NNP
( ||| S:2248 E:2249 ||| -LRB-
8 ||| S:2249 E:2250 ||| CD
%  ||| S:2250 E:2252 ||| NN
at  ||| S:2252 E:2255 ||| IN
1  ||| S:2255 E:2257 ||| CD
year ||| S:2257 E:2261 ||| NN
,  ||| S:2261 E:2263 ||| ,
54 ||| S:2263 E:2265 ||| CD
%  ||| S:2265 E:2267 ||| NN
at  ||| S:2267 E:2270 ||| IN
10  ||| S:2270 E:2273 ||| CD
years ||| S:2273 E:2278 ||| NNS
) ||| S:2278 E:2279 ||| -RRB-
.  ||| S:2279 E:2281 ||| .
Although  ||| S:2281 E:2290 ||| IN
mortality  ||| S:2290 E:2300 ||| NN
on  ||| S:2300 E:2303 ||| IN
RRT  ||| S:2303 E:2307 ||| NNP
is  ||| S:2307 E:2310 ||| VBZ
not  ||| S:2310 E:2314 ||| RB
particularly  ||| S:2314 E:2327 ||| RB
high  ||| S:2327 E:2332 ||| JJ
in  ||| S:2332 E:2335 ||| IN
Veneto  ||| S:2335 E:2342 ||| NNP
by  ||| S:2342 E:2345 ||| IN
comparison  ||| S:2345 E:2356 ||| NN
with  ||| S:2356 E:2361 ||| IN
countries  ||| S:2361 E:2371 ||| NNS
other  ||| S:2371 E:2377 ||| JJ
than  ||| S:2377 E:2382 ||| IN
Italy ||| S:2382 E:2387 ||| NNP
,  ||| S:2387 E:2389 ||| ,
this  ||| S:2389 E:2394 ||| DT
result  ||| S:2394 E:2401 ||| NN
is  ||| S:2401 E:2404 ||| VBZ
mainly  ||| S:2404 E:2411 ||| RB
due  ||| S:2411 E:2415 ||| JJ
to  ||| S:2415 E:2418 ||| TO
an  ||| S:2418 E:2421 ||| DT
increasing  ||| S:2421 E:2432 ||| JJ
number  ||| S:2432 E:2439 ||| NN
of  ||| S:2439 E:2442 ||| IN
patients  ||| S:2442 E:2451 ||| NNS
receiving  ||| S:2451 E:2461 ||| VBG
transplants ||| S:2461 E:2472 ||| NNS
,  ||| S:2472 E:2474 ||| ,
which  ||| S:2474 E:2480 ||| WDT
makes  ||| S:2480 E:2486 ||| VBZ
them  ||| S:2486 E:2491 ||| PRP
a  ||| S:2491 E:2493 ||| DT
favorably  ||| S:2493 E:2503 ||| RB
selected  ||| S:2503 E:2512 ||| VBN
population ||| S:2512 E:2522 ||| NN
.  ||| S:2522 E:2524 ||| .
The  ||| S:2524 E:2528 ||| DT
mortality  ||| S:2528 E:2538 ||| NN
rate  ||| S:2538 E:2543 ||| NN
was  ||| S:2543 E:2547 ||| VBD
high  ||| S:2547 E:2552 ||| JJ
among  ||| S:2552 E:2558 ||| IN
those  ||| S:2558 E:2564 ||| DT
on  ||| S:2564 E:2567 ||| IN
HD ||| S:2567 E:2569 ||| NNP
,  ||| S:2569 E:2571 ||| ,
particularly  ||| S:2571 E:2584 ||| RB
in  ||| S:2584 E:2587 ||| IN
the  ||| S:2587 E:2591 ||| DT
first  ||| S:2591 E:2597 ||| JJ
year ||| S:2597 E:2601 ||| NN
.  ||| S:2601 E:2603 ||| .
Our  ||| S:2603 E:2607 ||| PRP$
population  ||| S:2607 E:2618 ||| NN
on  ||| S:2618 E:2621 ||| IN
RRT  ||| S:2621 E:2625 ||| NNP
is  ||| S:2625 E:2628 ||| VBZ
rather  ||| S:2628 E:2635 ||| RB
heterogeneous ||| S:2635 E:2648 ||| JJ
,  ||| S:2648 E:2650 ||| ,
and  ||| S:2650 E:2654 ||| CC
a  ||| S:2654 E:2656 ||| DT
description  ||| S:2656 E:2668 ||| NN
of  ||| S:2668 E:2671 ||| IN
the  ||| S:2671 E:2675 ||| DT
outcomes  ||| S:2675 E:2684 ||| NN
based  ||| S:2684 E:2690 ||| VBN
only  ||| S:2690 E:2695 ||| RB
on  ||| S:2695 E:2698 ||| IN
the  ||| S:2698 E:2702 ||| DT
whole  ||| S:2702 E:2708 ||| JJ
population  ||| S:2708 E:2719 ||| NN
may  ||| S:2719 E:2723 ||| MD
be  ||| S:2723 E:2726 ||| VB
misleading ||| S:2726 E:2736 ||| JJ
.  ||| S:2736 E:2738 ||| .
